Anders Lundqvist
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems 10
- Advanced Drug Delivery Systems 9
- Dermatology top 5%
- Dermatological and COVID-19 studies 7
- Infectious Diseases top 10%
- Parvovirus B19 Infection Studies 8
-
- Drug Transport and Resistance Mechanisms 9
-
- Inhalation and Respiratory Drug Delivery 6
-
- Asthma and respiratory diseases 6
-
- Advanced Chemical Sensor Technologies 3
- Co-authors
- Kalle SigfridssonHans LennernäsDavid DahlgrenErik SjögrenChrister TannergrenOwe OrwarMarkus FridénMarkus Sjöblom
- Journals
- Molecular Pharmaceutics (3 papers)Infectious Diseases (3 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Anders Lundqvist
43 papers receiving 874 citations
Peers
Comparison fields: 5 of 108
- Pharmaceutical Science 267
- Dermatology 111
- Infectious Diseases 157
- Applied Microbiology and Biotechnology 17
- Oncology 187
Countries citing papers authored by Anders Lundqvist
This map shows the geographic impact of Anders Lundqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Lundqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Lundqvist more than expected).
Fields of papers citing papers by Anders Lundqvist
This network shows the impact of papers produced by Anders Lundqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Lundqvist. The network helps show where Anders Lundqvist may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anders Lundqvist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 18 | |
| 3 | 2020 | 2 | |
| 4 | 2019 | 22 | |
| 5 | 2018 | 28 | |
| 6 | 2018 | 20 | |
| 7 | 2018 | 41 | |
| 8 | 2017 | 37 | |
| 9 | 2016 | 19 | |
| 10 | 2015 | 37 | |
| 11 | 2014 | 5 | |
| 12 | 2013 | 8 | |
| 13 | 2012 | 6 | |
| 14 | 2011 | 30 | |
| 15 | 2011 | 8 | |
| 16 | 2010 | 27 | |
| 17 | 2009 | 62 | |
| 18 | 2005 | 15 | |
| 19 | 2005 | 23 | |
| 20 | 2003 | 18 |
About Anders Lundqvist
Anders Lundqvist is a scholar working on Pharmaceutical Science, Dermatology, Gastroenterology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 44 papers that have together received 901 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (10 papers), Advanced Drug Delivery Systems (9 papers), Drug Transport and Resistance Mechanisms (9 papers), Parvovirus B19 Infection Studies (8 papers), Dermatological and COVID-19 studies (7 papers), Inhalation and Respiratory Drug Delivery (6 papers), Asthma and respiratory diseases (6 papers) and Advanced Chemical Sensor Technologies (3 papers). The work is most often cited by research in Pharmaceutical Science (267 citations), Dermatology (111 citations), Infectious Diseases (157 citations), Applied Microbiology and Biotechnology (17 citations) and Oncology (187 citations). Anders Lundqvist has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Kalle Sigfridsson, Hans Lennernäs, David Dahlgren, Erik Sjögren, Christer Tannergren, Owe Orwar, Markus Fridén, Markus Sjöblom, Carl Roos and Christian Roos. Their work appears in journals such as Molecular Pharmaceutics, Infectious Diseases, Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.